Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03834766 · ClinicalTrials.gov registry record · Phase 3
Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD
A Phase 3 study, sponsored by Tris Pharma.
- Completed
- Registry status
- Phase 3
- Development phase
- 130
- Enrollment target
NCT03834766: Completed Phase 3 study, sponsored by Tris Pharma.
NCT03834766 is a Phase 3 study that has completed, run by Tris Pharma. The registered enrollment target is 130 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03834766, a Phase 3 study, has completed, sponsored by Tris Pharma.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 130 participants
- Enrollment target
Study Summary
To evaluate the efficacy of AMPH ER TAB compared to placebo in adult patients with ADHD aged 18 to 60 years.
Primary Outcome
The Total Math Score is the sum of the number of math problems attempted plus the number of math problems answered correctly and it provides an objective measure of performance that is time-sensitive, ADHD medication-sensitive, and well documented as a measure to evaluate ADHD medication effectiveness throughout the day. The Total Math Score ranges from 0-800 with higher scores indicating better performance.
Interventions
- DRUG AMPH ER Tab 5, 10, 15 and 20 mg
- DRUG AMPH ER Tab Matching Placebo 5, 10, 15 and 20 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2019-02-06 |
| Est. Completion | 2019-10-19 |
| Phase | Phase 3 |
What the finished NCT03834766 record still lists
NCT03834766 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which AMPH ER Tab 5, 10, 15 and 20 mg is the first listed.
NCT03834766 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03834766 about?
NCT03834766 is a clinical study titled "Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD". To evaluate the efficacy of AMPH ER TAB compared to placebo in adult patients with ADHD aged 18 to 60 years.
What is the current status of trial NCT03834766?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 130 participants. The study started on 2019-02-06. Estimated completion is 2019-10-19.
What interventions are being tested in trial NCT03834766?
The interventions under investigation include: AMPH ER Tab 5, 10, 15 and 20 mg (DRUG), AMPH ER Tab Matching Placebo 5, 10, 15 and 20 mg (DRUG).
Who is sponsoring clinical trial NCT03834766?
This trial is sponsored by Tris Pharma, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03834766's enrollment target sits among peer trials
130 1594th of 2000 higher than 404 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI